Biopharmaceutical company PlasmaGen Biosciences has raised ₹150 crore in a fresh funding round led by ViNS Bioproducts, with participation from high-net-worth individuals (HNIs), family offices, pharmaceutical entrepreneurs, and existing investors, the company said. The latest fundraise values the Bengaluru-based company at over ₹1,500 crore and takes its total capital raised to more than ₹600 crore … Continue reading PlasmaGen Biosciences Raises ₹150 Cr Funding at Over ₹1,500 Cr Valuation